$DGX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in QUEST DIAGNOSTICS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in QUEST DIAGNOSTICS INC. Get notifications about new insider transactions in QUEST DIAGNOSTICS INC for free.
Page: < prev 1 ... 2 3 4 5 6 7 8 9 ... 18 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 23 2017 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Grant | A | 0.00 | 3,132 | 0 | 76,512 | 73.4 K to 76.5 K (+4.27 %) |
| Feb 23 2017 | DGX | QUEST DIAGNOSTICS ... | Davis J. E. | EVP, General Diagno ... | Option Exercise | A | 95.80 | 55,093 | 5,277,634 | 55,093 | |
| Feb 23 2017 | DGX | QUEST DIAGNOSTICS ... | Davis J. E. | EVP, General Diagno ... | Grant | A | 0.00 | 4,594 | 0 | 33,673 | 29.1 K to 33.7 K (+15.80 %) |
| Feb 23 2017 | DGX | QUEST DIAGNOSTICS ... | Cohen Jon R | SVP & Group Exec. D ... | Option Exercise | A | 95.80 | 37,565 | 3,598,539 | 37,565 | |
| Feb 23 2017 | DGX | QUEST DIAGNOSTICS ... | Cohen Jon R | SVP & Group Exec. D ... | Grant | A | 0.00 | 3,132 | 0 | 67,944 | 64.8 K to 67.9 K (+4.83 %) |
| Feb 23 2017 | DGX | QUEST DIAGNOSTICS ... | Cunningham Everett | SVP, Commercial | Option Exercise | A | 95.80 | 37,565 | 3,598,539 | 37,565 | |
| Feb 23 2017 | DGX | QUEST DIAGNOSTICS ... | Cunningham Everett | SVP, Commercial | Grant | A | 0.00 | 3,132 | 0 | 34,201 | 31.1 K to 34.2 K (+10.08 %) |
| Feb 17 2017 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clin. Franchis ... | Sell | S | 94.65 | 1,615 | 152,858 | 73,380 | 75 K to 73.4 K (-2.15 %) |
| Feb 15 2017 | DGX | QUEST DIAGNOSTICS ... | RUSCKOWSKI STEPHEN H | Chairman, President ... | Payment of Exercise | F | 93.85 | 5,686 | 533,631 | 135,011 | 140.7 K to 135 K (-4.04 %) |
| Feb 15 2017 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Sell | S | 93.76 | 1,200 | 112,512 | 39,493 | 40.7 K to 39.5 K (-2.95 %) |
| Feb 15 2017 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Payment of Exercise | F | 93.85 | 1,293 | 121,348 | 40,693 | 42 K to 40.7 K (-3.08 %) |
| Feb 15 2017 | DGX | QUEST DIAGNOSTICS ... | GUINAN MARK | Executive Vice Pres ... | Payment of Exercise | F | 93.85 | 1,451 | 136,176 | 39,436 | 40.9 K to 39.4 K (-3.55 %) |
| Feb 15 2017 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clin. Franchis ... | Payment of Exercise | F | 93.85 | 1,740 | 163,299 | 74,995 | 76.7 K to 75 K (-2.27 %) |
| Feb 15 2017 | DGX | QUEST DIAGNOSTICS ... | Davis J. E. | EVP, General Diagno ... | Payment of Exercise | F | 93.85 | 1,529 | 143,497 | 29,079 | 30.6 K to 29.1 K (-5.00 %) |
| Feb 15 2017 | DGX | QUEST DIAGNOSTICS ... | Cunningham Everett | SVP, Commercial | Payment of Exercise | F | 93.85 | 1,278 | 119,940 | 31,069 | 32.3 K to 31.1 K (-3.95 %) |
| Feb 15 2017 | DGX | QUEST DIAGNOSTICS ... | Cohen Jon R | SVP, Diagnostic Sol ... | Payment of Exercise | F | 93.85 | 1,274 | 119,565 | 64,812 | 66.1 K to 64.8 K (-1.93 %) |
| Feb 06 2017 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Option Exercise | M | 55.65 | 15,000 | 834,750 | 15,000 | |
| Feb 06 2017 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Option Exercise | M | 51.20 | 30,000 | 1,536,000 | 0 | |
| Feb 06 2017 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Sell | S | 92.38 | 15,000 | 1,385,745 | 41,986 | 57 K to 42 K (-26.32 %) |
| Feb 06 2017 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Buy | M | 55.65 | 15,000 | 834,750 | 56,918 | 41.9 K to 56.9 K (+35.78 %) |
| Feb 06 2017 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Sell | S | 92.40 | 30,000 | 2,771,850 | 41,918 | 71.9 K to 41.9 K (-41.71 %) |
| Feb 06 2017 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Buy | M | 51.20 | 30,000 | 1,536,000 | 71,918 | 41.9 K to 71.9 K (+71.57 %) |
| Feb 01 2017 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clin. Franchis ... | Option Exercise | M | 56.12 | 37,414 | 2,099,674 | 6,595 | |
| Feb 01 2017 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clin. Franchis ... | Option Exercise | M | 52.17 | 42,586 | 2,221,499 | 21,294 | |
| Feb 01 2017 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clin. Franchis ... | Sell | S | 90.40 | 37,414 | 3,382,076 | 76,735 | 114.1 K to 76.7 K (-32.78 %) |
| Feb 01 2017 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clin. Franchis ... | Buy | M | 56.12 | 37,414 | 2,099,674 | 114,149 | 76.7 K to 114.1 K (+48.76 %) |
| Feb 01 2017 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clin. Franchis ... | Sell | S | 91.61 | 11,486 | 1,052,255 | 76,735 | 88.2 K to 76.7 K (-13.02 %) |
| Feb 01 2017 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clin. Franchis ... | Sell | S | 90.42 | 31,100 | 2,812,031 | 88,221 | 119.3 K to 88.2 K (-26.06 %) |
| Feb 01 2017 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clin. Franchis ... | Buy | M | 52.17 | 42,586 | 2,221,499 | 119,321 | 76.7 K to 119.3 K (+55.50 %) |
| Jan 05 2017 | DGX | QUEST DIAGNOSTICS ... | RING TIMOTHY M | Director | Option Exercise | A | 0.00 | 333 | 0 | 4,878 | |
| Nov 17 2016 | DGX | QUEST DIAGNOSTICS ... | PFEIFFER GARY M | Director | Option Exercise | M | 61.23 | 6,111 | 374,146 | 0 | |
| Nov 17 2016 | DGX | QUEST DIAGNOSTICS ... | PFEIFFER GARY M | Director | Option Exercise | M | 57.57 | 6,111 | 351,780 | 0 | |
| Nov 17 2016 | DGX | QUEST DIAGNOSTICS ... | PFEIFFER GARY M | Director | Option Exercise | M | 57.67 | 6,111 | 352,421 | 0 | |
| Nov 17 2016 | DGX | QUEST DIAGNOSTICS ... | PFEIFFER GARY M | Director | Option Exercise | M | 55.76 | 8,000 | 446,080 | 0 | |
| Nov 17 2016 | DGX | QUEST DIAGNOSTICS ... | PFEIFFER GARY M | Director | Option Exercise | M | 51.55 | 8,000 | 412,400 | 0 | |
| Nov 17 2016 | DGX | QUEST DIAGNOSTICS ... | PFEIFFER GARY M | Director | Sell | S | 85.25 | 8,310 | 708,461 | 13,698 | 22 K to 13.7 K (-37.76 %) |
| Nov 17 2016 | DGX | QUEST DIAGNOSTICS ... | PFEIFFER GARY M | Director | Sell | S | 85.18 | 6,111 | 520,559 | 22,008 | 28.1 K to 22 K (-21.73 %) |
| Nov 17 2016 | DGX | QUEST DIAGNOSTICS ... | PFEIFFER GARY M | Director | Buy | M | 61.23 | 6,111 | 374,146 | 28,119 | 22 K to 28.1 K (+27.77 %) |
| Nov 17 2016 | DGX | QUEST DIAGNOSTICS ... | PFEIFFER GARY M | Director | Sell | S | 85.09 | 6,111 | 519,973 | 22,008 | 28.1 K to 22 K (-21.73 %) |
| Nov 17 2016 | DGX | QUEST DIAGNOSTICS ... | PFEIFFER GARY M | Director | Buy | M | 57.57 | 6,111 | 351,780 | 28,119 | 22 K to 28.1 K (+27.77 %) |
| Nov 17 2016 | DGX | QUEST DIAGNOSTICS ... | PFEIFFER GARY M | Director | Sell | S | 85.07 | 6,111 | 519,832 | 22,008 | 28.1 K to 22 K (-21.73 %) |
| Nov 17 2016 | DGX | QUEST DIAGNOSTICS ... | PFEIFFER GARY M | Director | Buy | M | 57.67 | 6,111 | 352,391 | 28,119 | 22 K to 28.1 K (+27.77 %) |
| Nov 17 2016 | DGX | QUEST DIAGNOSTICS ... | PFEIFFER GARY M | Director | Sell | S | 84.94 | 8,000 | 679,504 | 22,008 | 30 K to 22 K (-26.66 %) |
| Nov 17 2016 | DGX | QUEST DIAGNOSTICS ... | PFEIFFER GARY M | Director | Buy | M | 55.76 | 8,000 | 446,080 | 30,008 | 22 K to 30 K (+36.35 %) |
| Nov 17 2016 | DGX | QUEST DIAGNOSTICS ... | PFEIFFER GARY M | Director | Sell | S | 85.01 | 8,000 | 680,096 | 22,008 | 30 K to 22 K (-26.66 %) |
| Nov 17 2016 | DGX | QUEST DIAGNOSTICS ... | PFEIFFER GARY M | Director | Buy | M | 51.55 | 8,000 | 412,400 | 30,008 | 22 K to 30 K (+36.35 %) |
| Oct 17 2016 | DGX | QUEST DIAGNOSTICS ... | Klug Robert A | VP, Corporate Contr ... | Grant | A | 0.00 | 91 | 0 | 3,043 | 3 K to 3 K (+3.08 %) |
| Oct 05 2016 | DGX | QUEST DIAGNOSTICS ... | RING TIMOTHY M | Director | Option Exercise | A | 0.00 | 367 | 0 | 4,523 | |
| Aug 24 2016 | DGX | QUEST DIAGNOSTICS ... | Klug Robert A | VP, Corporate Contr ... | Payment of Exercise | F | 84.57 | 84 | 7,104 | 2,888 | 3 K to 2.9 K (-2.83 %) |
| Aug 24 2016 | DGX | QUEST DIAGNOSTICS ... | GUINAN MARK | Senior Vice Preside ... | Payment of Exercise | F | 84.57 | 6,663 | 563,490 | 40,887 | 47.6 K to 40.9 K (-14.01 %) |
| Aug 24 2016 | DGX | QUEST DIAGNOSTICS ... | GUINAN MARK | Senior Vice Preside ... | Payment of Exercise | F | 84.57 | 1,777 | 150,281 | 47,550 | 49.3 K to 47.6 K (-3.60 %) |
| Aug 22 2016 | DGX | QUEST DIAGNOSTICS ... | Klug Robert A | VP, Corporate Contr ... | Payment of Exercise | F | 84.89 | 11 | 934 | 2,972 | 3 K to 3 K (-0.37 %) |
| Aug 22 2016 | DGX | QUEST DIAGNOSTICS ... | BRITELL JENNE K | Director | Option Exercise | M | 55.76 | 4,000 | 223,040 | 0 | |
| Aug 22 2016 | DGX | QUEST DIAGNOSTICS ... | BRITELL JENNE K | Director | Sell | S | 84.76 | 4,000 | 339,052 | 19,885 | 23.9 K to 19.9 K (-16.75 %) |
| Aug 22 2016 | DGX | QUEST DIAGNOSTICS ... | BRITELL JENNE K | Director | Buy | M | 55.76 | 4,000 | 223,040 | 23,885 | 19.9 K to 23.9 K (+20.12 %) |
| Aug 11 2016 | DGX | QUEST DIAGNOSTICS ... | BRITELL JENNE K | Director | Option Exercise | M | 55.76 | 4,000 | 223,040 | 4,000 | |
| Aug 11 2016 | DGX | QUEST DIAGNOSTICS ... | BRITELL JENNE K | Director | Sell | S | 85.20 | 4,000 | 340,808 | 19,885 | 23.9 K to 19.9 K (-16.75 %) |
| Aug 11 2016 | DGX | QUEST DIAGNOSTICS ... | BRITELL JENNE K | Director | Buy | M | 55.76 | 4,000 | 223,040 | 23,876 | 19.9 K to 23.9 K (+20.12 %) |
| Aug 04 2016 | DGX | QUEST DIAGNOSTICS ... | LEIDEN JEFFREY M | Director | Option Exercise | M | 70.37 | 311 | 21,885 | 0 | |
| Aug 04 2016 | DGX | QUEST DIAGNOSTICS ... | LEIDEN JEFFREY M | Director | Option Exercise | M | 70.37 | 311 | 21,885 | 0 | |
| Aug 04 2016 | DGX | QUEST DIAGNOSTICS ... | LEIDEN JEFFREY M | Director | Option Exercise | M | 61.37 | 1,747 | 107,213 | 0 | |
| Aug 04 2016 | DGX | QUEST DIAGNOSTICS ... | LEIDEN JEFFREY M | Director | Option Exercise | M | 61.37 | 1,747 | 107,213 | 0 | |
| Aug 04 2016 | DGX | QUEST DIAGNOSTICS ... | LEIDEN JEFFREY M | Director | Option Exercise | M | 72.92 | 1,563 | 113,974 | 0 | |
| Aug 04 2016 | DGX | QUEST DIAGNOSTICS ... | LEIDEN JEFFREY M | Director | Option Exercise | M | 72.92 | 1,563 | 113,974 | 0 | |
| Aug 04 2016 | DGX | QUEST DIAGNOSTICS ... | LEIDEN JEFFREY M | Director | Option Exercise | M | 76.07 | 1,518 | 115,467 | 0 | |
| Aug 04 2016 | DGX | QUEST DIAGNOSTICS ... | LEIDEN JEFFREY M | Director | Option Exercise | M | 76.07 | 1,518 | 115,467 | 0 | |
| Aug 04 2016 | DGX | QUEST DIAGNOSTICS ... | LEIDEN JEFFREY M | Director | Option Exercise | M | 68.68 | 1,502 | 103,157 | 0 | |
| Aug 04 2016 | DGX | QUEST DIAGNOSTICS ... | LEIDEN JEFFREY M | Director | Option Exercise | M | 68.68 | 1,502 | 103,157 | 0 | |
| Aug 04 2016 | DGX | QUEST DIAGNOSTICS ... | LEIDEN JEFFREY M | Director | Sell | S | 85.61 | 311 | 26,625 | 6,027 | 6.3 K to 6 K (-4.91 %) |
| Aug 04 2016 | DGX | QUEST DIAGNOSTICS ... | LEIDEN JEFFREY M | Director | Sell | S | 85.61 | 311 | 26,625 | 6,027 | 6.3 K to 6 K (-4.91 %) |
| Aug 04 2016 | DGX | QUEST DIAGNOSTICS ... | LEIDEN JEFFREY M | Director | Buy | M | 70.37 | 311 | 21,885 | 6,338 | 6 K to 6.3 K (+5.16 %) |
| Aug 04 2016 | DGX | QUEST DIAGNOSTICS ... | LEIDEN JEFFREY M | Director | Buy | M | 70.37 | 311 | 21,885 | 6,338 | 6 K to 6.3 K (+5.16 %) |
| Aug 04 2016 | DGX | QUEST DIAGNOSTICS ... | LEIDEN JEFFREY M | Director | Sell | S | 85.57 | 1,747 | 149,486 | 6,027 | 7.8 K to 6 K (-22.47 %) |
| Aug 04 2016 | DGX | QUEST DIAGNOSTICS ... | LEIDEN JEFFREY M | Director | Sell | S | 85.57 | 1,747 | 149,486 | 6,027 | 7.8 K to 6 K (-22.47 %) |
| Aug 04 2016 | DGX | QUEST DIAGNOSTICS ... | LEIDEN JEFFREY M | Director | Buy | M | 61.37 | 1,747 | 107,213 | 7,774 | 6 K to 7.8 K (+28.99 %) |
| Aug 04 2016 | DGX | QUEST DIAGNOSTICS ... | LEIDEN JEFFREY M | Director | Buy | M | 61.37 | 1,747 | 107,213 | 7,774 | 6 K to 7.8 K (+28.99 %) |
| Aug 04 2016 | DGX | QUEST DIAGNOSTICS ... | LEIDEN JEFFREY M | Director | Sell | S | 85.65 | 1,563 | 133,866 | 6,027 | 7.6 K to 6 K (-20.59 %) |
| Aug 04 2016 | DGX | QUEST DIAGNOSTICS ... | LEIDEN JEFFREY M | Director | Sell | S | 85.65 | 1,563 | 133,866 | 6,027 | 7.6 K to 6 K (-20.59 %) |
| Aug 04 2016 | DGX | QUEST DIAGNOSTICS ... | LEIDEN JEFFREY M | Director | Buy | M | 72.92 | 1,563 | 113,974 | 7,590 | 6 K to 7.6 K (+25.93 %) |
| Aug 04 2016 | DGX | QUEST DIAGNOSTICS ... | LEIDEN JEFFREY M | Director | Buy | M | 72.92 | 1,563 | 113,974 | 7,590 | 6 K to 7.6 K (+25.93 %) |
| Aug 04 2016 | DGX | QUEST DIAGNOSTICS ... | LEIDEN JEFFREY M | Director | Sell | S | 85.66 | 800 | 68,526 | 6,027 | 6.8 K to 6 K (-11.72 %) |
| Aug 04 2016 | DGX | QUEST DIAGNOSTICS ... | LEIDEN JEFFREY M | Director | Sell | S | 85.66 | 800 | 68,526 | 6,027 | 6.8 K to 6 K (-11.72 %) |
| Aug 04 2016 | DGX | QUEST DIAGNOSTICS ... | LEIDEN JEFFREY M | Director | Sell | S | 85.65 | 718 | 61,497 | 6,827 | 7.5 K to 6.8 K (-9.52 %) |
| Aug 04 2016 | DGX | QUEST DIAGNOSTICS ... | LEIDEN JEFFREY M | Director | Sell | S | 85.65 | 718 | 61,497 | 6,827 | 7.5 K to 6.8 K (-9.52 %) |
| Aug 04 2016 | DGX | QUEST DIAGNOSTICS ... | LEIDEN JEFFREY M | Director | Buy | M | 76.07 | 1,518 | 115,467 | 7,545 | 6 K to 7.5 K (+25.19 %) |
| Aug 04 2016 | DGX | QUEST DIAGNOSTICS ... | LEIDEN JEFFREY M | Director | Buy | M | 76.07 | 1,518 | 115,467 | 7,545 | 6 K to 7.5 K (+25.19 %) |
| Aug 04 2016 | DGX | QUEST DIAGNOSTICS ... | LEIDEN JEFFREY M | Director | Sell | S | 85.62 | 1,206 | 103,263 | 6,027 | 7.2 K to 6 K (-16.67 %) |
| Aug 04 2016 | DGX | QUEST DIAGNOSTICS ... | LEIDEN JEFFREY M | Director | Sell | S | 85.62 | 1,206 | 103,263 | 6,027 | 7.2 K to 6 K (-16.67 %) |
| Aug 04 2016 | DGX | QUEST DIAGNOSTICS ... | LEIDEN JEFFREY M | Director | Buy | M | 68.68 | 1,502 | 103,157 | 7,233 | 5.7 K to 7.2 K (+26.21 %) |
| Aug 04 2016 | DGX | QUEST DIAGNOSTICS ... | LEIDEN JEFFREY M | Director | Buy | M | 68.68 | 1,502 | 103,157 | 7,233 | 5.7 K to 7.2 K (+26.21 %) |
| Jul 27 2016 | DGX | QUEST DIAGNOSTICS ... | ZIEGLER JOHN B | Director | Sell | S | 84.36 | 1,000 | 84,359 | 18,557 | 19.6 K to 18.6 K (-5.11 %) |
| Jul 05 2016 | DGX | QUEST DIAGNOSTICS ... | RING TIMOTHY M | Director | Option Exercise | A | 0.00 | 381 | 0 | 4,136 | |
| Jun 01 2016 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clin. Franchis ... | Option Exercise | M | 56.82 | 23,667 | 1,344,759 | 0 | |
| Jun 01 2016 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clin. Franchis ... | Option Exercise | M | 55.65 | 23,667 | 1,317,069 | 0 | |
| Jun 01 2016 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clin. Franchis ... | Sell | S | 77.26 | 23,667 | 1,828,607 | 76,735 | 100.4 K to 76.7 K (-23.57 %) |
| Jun 01 2016 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clin. Franchis ... | Sell | S | 77.27 | 23,667 | 1,828,702 | 100,402 | 124.1 K to 100.4 K (-19.08 %) |
| Jun 01 2016 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clin. Franchis ... | Buy | M | 56.82 | 23,667 | 1,344,759 | 124,069 | 100.4 K to 124.1 K (+23.57 %) |
| Jun 01 2016 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clin. Franchis ... | Buy | M | 55.65 | 23,667 | 1,317,069 | 100,402 | 76.7 K to 100.4 K (+30.84 %) |
| May 25 2016 | DGX | QUEST DIAGNOSTICS ... | Davis J. E. | SVP, Regional Busin ... | Payment of Exercise | F | 76.30 | 1,907 | 145,504 | 30,077 | 32 K to 30.1 K (-5.96 %) |
| May 19 2016 | DGX | QUEST DIAGNOSTICS ... | WILENSKY GAIL R | Director | Grant | A | 0.00 | 2,196 | 0 | 23,387 | 21.2 K to 23.4 K (+10.36 %) |
| May 19 2016 | DGX | QUEST DIAGNOSTICS ... | ZIEGLER JOHN B | Director | Grant | A | 0.00 | 2,196 | 0 | 19,539 | 17.3 K to 19.5 K (+12.66 %) |
| May 19 2016 | DGX | QUEST DIAGNOSTICS ... | STANZIONE DANIEL | Director | Grant | A | 0.00 | 3,275 | 0 | 33,102 | 29.8 K to 33.1 K (+10.98 %) |
| May 19 2016 | DGX | QUEST DIAGNOSTICS ... | RING TIMOTHY M | Director | Grant | A | 0.00 | 2,196 | 0 | 12,767 | 10.6 K to 12.8 K (+20.77 %) |
| May 19 2016 | DGX | QUEST DIAGNOSTICS ... | PFEIFFER GARY M | Director | Grant | A | 0.00 | 2,196 | 0 | 22,008 | 19.8 K to 22 K (+11.08 %) |
| May 19 2016 | DGX | QUEST DIAGNOSTICS ... | MAIN TIMOTHY L | Director | Grant | A | 0.00 | 2,196 | 0 | 13,118 | 10.9 K to 13.1 K (+20.11 %) |
| May 19 2016 | DGX | QUEST DIAGNOSTICS ... | LEIDEN JEFFREY M | Director | Grant | A | 0.00 | 2,196 | 0 | 5,731 | 3.5 K to 5.7 K (+62.12 %) |
| May 19 2016 | DGX | QUEST DIAGNOSTICS ... | Gregg Vicky B | Director | Grant | A | 0.00 | 2,196 | 0 | 6,906 | 4.7 K to 6.9 K (+46.62 %) |
| May 19 2016 | DGX | QUEST DIAGNOSTICS ... | BRITELL JENNE K | Director | Grant | A | 0.00 | 2,196 | 0 | 19,876 | 17.7 K to 19.9 K (+12.42 %) |
| May 16 2016 | DGX | QUEST DIAGNOSTICS ... | BRITELL JENNE K | Director | Option Exercise | M | 51.55 | 8,000 | 412,400 | 0 | |
| May 16 2016 | DGX | QUEST DIAGNOSTICS ... | BRITELL JENNE K | Director | Sell | S | 75.68 | 8,000 | 605,456 | 11,655 | 19.7 K to 11.7 K (-40.70 %) |
| May 16 2016 | DGX | QUEST DIAGNOSTICS ... | BRITELL JENNE K | Director | Buy | M | 51.55 | 8,000 | 412,400 | 19,655 | 11.7 K to 19.7 K (+68.64 %) |
| May 11 2016 | DGX | QUEST DIAGNOSTICS ... | Cunningham Everett | SVP, Commercial | Option Exercise | M | 71.17 | 13,252 | 943,145 | 40,328 | |
| May 11 2016 | DGX | QUEST DIAGNOSTICS ... | Cunningham Everett | SVP, Commercial | Option Exercise | M | 56.12 | 43,060 | 2,416,527 | 0 | |
| May 11 2016 | DGX | QUEST DIAGNOSTICS ... | Cunningham Everett | SVP, Commercial | Sell | S | 76.21 | 13,252 | 1,009,908 | 31,889 | 45.1 K to 31.9 K (-29.36 %) |
| May 11 2016 | DGX | QUEST DIAGNOSTICS ... | Cunningham Everett | SVP, Commercial | Buy | M | 71.17 | 13,252 | 943,145 | 45,141 | 31.9 K to 45.1 K (+41.56 %) |
| May 11 2016 | DGX | QUEST DIAGNOSTICS ... | Cunningham Everett | SVP, Commercial | Sell | S | 76.28 | 43,060 | 3,284,488 | 31,889 | 74.9 K to 31.9 K (-57.45 %) |
| May 11 2016 | DGX | QUEST DIAGNOSTICS ... | Cunningham Everett | SVP, Commercial | Buy | M | 56.12 | 43,060 | 2,416,527 | 74,949 | 31.9 K to 74.9 K (+135.03 %) |
| May 09 2016 | DGX | QUEST DIAGNOSTICS ... | Cunningham Everett | SVP, Commercial | Option Exercise | M | 71.17 | 6,912 | 491,927 | 53,580 | |
| May 09 2016 | DGX | QUEST DIAGNOSTICS ... | Cunningham Everett | SVP, Commercial | Option Exercise | M | 52.17 | 42,586 | 2,221,499 | 21,294 | |
| May 09 2016 | DGX | QUEST DIAGNOSTICS ... | Cunningham Everett | SVP, Commercial | Option Exercise | M | 56.12 | 949 | 53,258 | 43,060 | |
| May 09 2016 | DGX | QUEST DIAGNOSTICS ... | Cunningham Everett | SVP, Commercial | Sell | S | 76.00 | 6,912 | 525,312 | 31,889 | 38.8 K to 31.9 K (-17.81 %) |
| May 09 2016 | DGX | QUEST DIAGNOSTICS ... | Cunningham Everett | SVP, Commercial | Buy | M | 71.17 | 6,912 | 491,927 | 38,612 | 31.7 K to 38.6 K (+21.80 %) |
| May 09 2016 | DGX | QUEST DIAGNOSTICS ... | Cunningham Everett | SVP, Commercial | Sell | S | 76.00 | 42,586 | 3,236,536 | 31,700 | 74.3 K to 31.7 K (-57.33 %) |
| May 09 2016 | DGX | QUEST DIAGNOSTICS ... | Cunningham Everett | SVP, Commercial | Buy | M | 52.17 | 42,586 | 2,221,499 | 74,286 | 31.7 K to 74.3 K (+134.34 %) |
| May 09 2016 | DGX | QUEST DIAGNOSTICS ... | Cunningham Everett | SVP, Commercial | Sell | S | 76.00 | 949 | 72,124 | 31,700 | 32.6 K to 31.7 K (-2.91 %) |
| May 09 2016 | DGX | QUEST DIAGNOSTICS ... | Cunningham Everett | SVP, Commercial | Buy | M | 56.12 | 949 | 53,258 | 32,649 | 31.7 K to 32.6 K (+2.99 %) |
| Apr 05 2016 | DGX | QUEST DIAGNOSTICS ... | RING TIMOTHY M | Director | Option Exercise | A | 0.00 | 430 | 0 | 3,735 | |
| Mar 03 2016 | DGX | QUEST DIAGNOSTICS ... | Cohen Jon R | SVP, Diagnostic Sol ... | Payment of Exercise | F | 66.51 | 1,323 | 87,993 | 66,086 | 67.4 K to 66.1 K (-1.96 %) |
| Mar 03 2016 | DGX | QUEST DIAGNOSTICS ... | Cohen Jon R | SVP, Diagnostic Sol ... | Payment of Exercise | F | 67.01 | 1,000 | 67,010 | 67,409 | 68.4 K to 67.4 K (-1.46 %) |
| Mar 03 2016 | DGX | QUEST DIAGNOSTICS ... | Cohen Jon R | SVP, Diagnostic Sol ... | Grant | A | 67.01 | 2,684 | 179,855 | 68,409 | 65.7 K to 68.4 K (+4.08 %) |
| Mar 03 2016 | DGX | QUEST DIAGNOSTICS ... | GUINAN MARK | Senior Vice Preside ... | Payment of Exercise | F | 67.01 | 966 | 64,732 | 49,327 | 50.3 K to 49.3 K (-1.92 %) |
| Mar 03 2016 | DGX | QUEST DIAGNOSTICS ... | GUINAN MARK | Senior Vice Preside ... | Grant | A | 67.01 | 2,591 | 173,623 | 50,293 | 47.7 K to 50.3 K (+5.43 %) |
| Mar 03 2016 | DGX | QUEST DIAGNOSTICS ... | Davis J. E. | SVP, Regional Busin ... | Payment of Exercise | F | 67.01 | 655 | 43,892 | 31,861 | 32.5 K to 31.9 K (-2.01 %) |
| Mar 03 2016 | DGX | QUEST DIAGNOSTICS ... | Davis J. E. | SVP, Regional Busin ... | Grant | A | 67.01 | 1,870 | 125,309 | 32,448 | 30.6 K to 32.4 K (+6.12 %) |
| Mar 03 2016 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Sell | S | 68.62 | 283 | 19,420 | 41,905 | 42.2 K to 41.9 K (-0.67 %) |
| Mar 03 2016 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Sell | S | 68.19 | 3,532 | 240,845 | 42,181 | 45.7 K to 42.2 K (-7.73 %) |
| Mar 03 2016 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Payment of Exercise | F | 66.51 | 919 | 61,123 | 45,713 | 46.6 K to 45.7 K (-1.97 %) |
| Mar 03 2016 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Payment of Exercise | F | 67.01 | 685 | 45,902 | 46,632 | 47.3 K to 46.6 K (-1.45 %) |
| Mar 03 2016 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Grant | A | 67.01 | 1,994 | 133,618 | 47,317 | 45.3 K to 47.3 K (+4.40 %) |
| Mar 03 2016 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clin. Franchis ... | Payment of Exercise | F | 66.51 | 1,305 | 86,796 | 82,618 | 83.9 K to 82.6 K (-1.55 %) |
| Mar 03 2016 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clin. Franchis ... | Payment of Exercise | F | 67.01 | 922 | 61,783 | 83,923 | 84.8 K to 83.9 K (-1.09 %) |
| Mar 03 2016 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clin. Franchis ... | Grant | A | 67.01 | 2,684 | 179,855 | 84,845 | 82.2 K to 84.8 K (+3.27 %) |
| Mar 03 2016 | DGX | QUEST DIAGNOSTICS ... | Klug Robert A | VP, Corporate Contr ... | Payment of Exercise | F | 67.01 | 72 | 4,825 | 2,797 | 2.9 K to 2.8 K (-2.51 %) |
| Mar 03 2016 | DGX | QUEST DIAGNOSTICS ... | Klug Robert A | VP, Corporate Contr ... | Grant | A | 67.01 | 184 | 12,330 | 2,830 | 2.6 K to 2.8 K (+6.95 %) |
| Mar 03 2016 | DGX | QUEST DIAGNOSTICS ... | Cunningham Everett | SVP, Commercial | Payment of Exercise | F | 66.51 | 1,323 | 87,993 | 31,700 | 33 K to 31.7 K (-4.01 %) |
| Mar 03 2016 | DGX | QUEST DIAGNOSTICS ... | Cunningham Everett | SVP, Commercial | Payment of Exercise | F | 67.01 | 1,000 | 67,010 | 32,956 | 34 K to 33 K (-2.94 %) |
| Mar 03 2016 | DGX | QUEST DIAGNOSTICS ... | Cunningham Everett | SVP, Commercial | Grant | A | 67.01 | 2,684 | 179,855 | 33,956 | 31.3 K to 34 K (+8.58 %) |
| Mar 03 2016 | DGX | QUEST DIAGNOSTICS ... | RUSCKOWSKI STEPHEN H | President and CEO | Payment of Exercise | F | 66.51 | 7,046 | 468,629 | 139,335 | 146.4 K to 139.3 K (-4.81 %) |
| Mar 03 2016 | DGX | QUEST DIAGNOSTICS ... | RUSCKOWSKI STEPHEN H | President and CEO | Payment of Exercise | F | 67.01 | 4,811 | 322,385 | 146,240 | 151.1 K to 146.2 K (-3.19 %) |
| Mar 03 2016 | DGX | QUEST DIAGNOSTICS ... | RUSCKOWSKI STEPHEN H | President and CEO | Grant | A | 67.01 | 10,273 | 688,394 | 151,051 | 140.8 K to 151.1 K (+7.30 %) |